Yayıncı "TÜBİTAK Scientific and Technological Research Council of Turkey" PubMed İndeksli Yayınlar Koleksiyonu için listeleme
Toplam kayıt 2, listelenen: 1-2
-
Rituximab treatment for difficult-to-treat nephrotic syndrome in children: A multicenter, retrospective study
(TÜBİTAK Scientific and Technological Research Council of Turkey, 2021)Background/aim: This study aimed to evaluate the efficacy of rituximab in children with difficult-to-treat nephrotic syndrome, considering the type of disease (steroid-sensitive or -resistant) and the dosing regimen. Materials ... -
Utilization of biotechnological drugs in rare diseases requiring the use of off-label drugs in children in Turkey
(TÜBİTAK Scientific and Technological Research Council of Turkey, 2021)Background/aim: Pediatric patients, especially those with rare diseases, represent a population that has a high tendency towards off label drug use (OLDU) and needs a more careful practice of pharmacotherapy than in adults. ...